A private Istanbul clinic offering mesenchymal stem cell and exosome treatments using donated umbilical cord tissue, led by a named chief medical director.
Istanbul StemCell is a private clinic in the Suadiye area of Kadikoy, on the Asian side of Istanbul, at Bagdat Caddesi No 393. The site names Dr Tuncay Tas as chief medical director and gives a telephone number and an email address for enquiries.
The clinic states that it specialises in mesenchymal stem cells taken from Wharton's jelly, the gelatinous tissue inside the umbilical cord, and that it also provides exosome therapy. Exosomes are small vesicles released by cells. Because the cord tissue comes from a donor rather than from the patient, treatment of this kind is allogeneic (from a donor); the site's language points that way, although it does not use the word.
The website lists a long range of conditions it associates with these treatments, spanning orthopaedic problems such as osteoarthritis and tendon injury, neurological conditions including autism, Parkinson's disease, Alzheimer's disease, multiple sclerosis and recovery after stroke, and general medical conditions such as diabetes, liver cirrhosis, chronic obstructive pulmonary disease and heart disease, along with hair restoration, erectile dysfunction and anti-ageing work. A reader should treat that breadth carefully: a single cell preparation offered across neurological, metabolic, cardiac and cosmetic conditions is a far wider claim than published evidence supports for most of those conditions, and the site does not set out trial evidence for them.
The clinic makes several strong marketing claims that this directory has not verified and does not endorse. It describes itself as the most trusted and leading name for stem cell treatment in Istanbul, states that more than ten thousand procedures have been carried out successfully, and says it addresses complex conditions often considered untreatable by conventional medicine. No independent source for those figures or that characterisation is given on the site. On its treatment pages the language is more cautious, using phrases about promising results and noting that studies are ongoing and more research is needed.
The site names more than thirty conditions. They are reproduced here as the site lists them, and their appearance is not an indication that the treatment works for them.
The site states that its main cell preparation is mesenchymal stem cells isolated from Wharton's jelly in donated umbilical cord tissue, and that it also uses exosomes.
The site names one clinician.
The clinic gives a single address, a first-floor suite at Bagdat Caddesi No 393 in Suadiye, Kadikoy, on the Asian side of Istanbul. It presents itself as an international destination for patients travelling to Turkey for treatment and publishes its site in English, Turkish, German and Dutch. The site does not describe its treatment rooms or laboratory, does not name an accrediting body, does not state a founding year, and names only one clinician. A reader planning to travel should ask for those details directly. Note also that the same suite address is used by the marketing website of R3 Stem Cell, a United States network, which suggests the premises serve more than one brand.
The site publishes no prices, no price ranges and no package costs. It asks prospective patients to make contact for a consultation instead.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.